EMD Millipore opens GMP bioproduction facility in France

Tuesday, September 25, 2012 12:02 PM

EMD Millipore, the Billerica, Mass.-based life science division of Merck, has opened its advanced GMP bioproduction facility in Martillac, France, offering a full, single-use process train to speed a molecule’s journey to the clinic.

The site will serve users of EMD Millipore’s provantage biodevelopment and clinical supply solutions, an “open source” manufacturing option that incorporates the latest technologies for upstream and downstream processes.

The open source approach provides customers with greater control over production. With a traditional outsourcing model, the customer’s process must fit the facility and the contract manufacturer controls the process. With ProVantage Solutions, EMD Millipore develops the process for further use by the customer.  

At the new facility, EMD Millipore provides access to proven technologies, process development expertise and validation services, offering a robust template that makes it possible to go from clone selection to GMP product in only 12 months. The facility offers GMP production of mammalian proteins for pre-clinical to phase II production at the 50L to 1,250L scale. For phase III and commercial production, customers can transfer manufacturing to any location, at any scale. This freedom brings enhanced flexibility to the molecule development and the manufacturing process.

“EMD Millipore leverages more than 25 years of biomanufacturing experience with 150 molecules in our new facility in France,” said Christophe Couturier, vice president of services and solutions, EMD Millipore. “As the basis for Provantage Solutions, our experts complement customers’ internal capabilities in a way that combines the best of in-house production and conventional outsourcing. The end result is increased productivity and an accelerated time to market.”

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 17

PPD, Medidata join their technologies for risk-based monitoring, adaptive trial design

ERT acquires eClinical Insights in "strategic combination" to gain cloud-based trial software platform, expertise

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs